financetom
Business
financetom
/
Business
/
Novo Nordisk halts work on cell therapy for diabetes to cut costs, Bloomberg News reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novo Nordisk halts work on cell therapy for diabetes to cut costs, Bloomberg News reports
Oct 10, 2025 9:13 AM

Oct 10 (Reuters) - Novo Nordisk has cut its

cell therapy division, which has been trying to find a cure for

type 1 diabetes, Bloomberg News reported on Friday, citing a

statement.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Olin's $75 Million AMMO Deal Boosts Winchester High-Margin Push
Olin's $75 Million AMMO Deal Boosts Winchester High-Margin Push
Jan 21, 2025
Olin Corporation ( OLN ) and AMMO, Inc. ( POWW ) shares are trading higher on Tuesday after Olin agreed to acquire AMMO’s small caliber ammunition manufacturing assets for $75 million. The transaction, funded through available liquidity, will integrate these assets into Olin’s Winchester Ammunition business. The acquisition includes AMMO’s brass shellcase capabilities and its 185,000-square-foot production facility in Manitowoc,...
Astrana Health Repurchases About $10.6 Million of its Common Shares
Astrana Health Repurchases About $10.6 Million of its Common Shares
Jan 21, 2025
10:52 AM EST, 01/21/2025 (MT Newswires) -- Astrana Health ( ASTH ) said Tuesday it repurchased 300,000 of its common shares on Friday for $35.17 apiece or about a total purchase price of roughly $10.6 million. The company purchased the shares from its shareholder Allied Physicians of California, it added. Astrana Health's ( ASTH ) stock rose 3% in recent...
RedCloud Files for IPO of 11 Million Shares
RedCloud Files for IPO of 11 Million Shares
Jan 21, 2025
10:59 AM EST, 01/21/2025 (MT Newswires) -- RedCloud said Tuesday it launched a proposed initial public offering of 11 million shares, with the IPO price currently expected at between $4 and $6 per share. Underwriters will be granted a 30-day option to purchase up to 1.7 million additional shares, the company said. The company said it plans to list its...
Market Chatter: International Paper Expected to Get EU Nod for DS Smith Takeover
Market Chatter: International Paper Expected to Get EU Nod for DS Smith Takeover
Jan 21, 2025
10:53 AM EST, 01/21/2025 (MT Newswires) -- International Paper ( IP ) is expected to get the European Commission's approval for its proposed acquisition of DS Smith after agreeing to sell assets to resolve competition concerns, Reuters reported Tuesday, citing people with knowledge of the matter. The regulator previously set a Jan. 24 provisional deadline for a decision on the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved